To examine whether the altered glucose utilization in Tamo-Re cells was associated with such changes, we analyzed the messenger RNA (mRNA) levels of members of the GLUT and SGLT1 GLUT families, particularly those frequently known to be altered in cancer cells. The gene discussed is SLC2A1; the disease is cancer.